Neoplasms clinical trials
The registry lists 9,328 studies for Neoplasms across more than 10 countries. 2,479 are recruiting or about to start. Per ClinicalTrials.gov, last updated 2026-09-25.
Status
- Completed
- 4,085
- Recruiting
- 1,844
- Terminated
- 932
- Status unknown
- 922
- Active, not recruiting
- 546
- Not yet recruiting
- 538
Phase
- Phase 1
- 3,735
- Phase 2
- 2,012
- Phase 3
- 423
- Early Phase 1
- 171
- Phase 4
- 112
Where
- United States
- 4,386
- China
- 1,462
- France
- 838
- Canada
- 613
- Spain
- 581
- United Kingdom
- 560
Who runs them
National Cancer Institute (NCI) (310) · M.D. Anderson Cancer Center (274) · AstraZeneca (101) · Novartis Pharmaceuticals (94) · Memorial Sloan Kettering Cancer Center (89) · Eli Lilly and Company (89) · AbbVie (76) · Mayo Clinic (73)
Studies
Recruiting first, then most recently updated. Showing 50 of 9,328 — search for more.
- A Rollover Study for Continued Study Treatment and Ongoing Safety MonitoringEnrolling by invitationNCT06788509Phase 115 countries
- Understanding and Anticipating Therapeutic and ADverse Responses in Anti-cancer Immune Checkpoint Inhibition Towards a Better Therapeutic Management of PatientsRecruitingNCT059733441 country
- Pharmacogenomic Testing in Pediatric Hematology/Oncology PatientsNot yet recruitingNCT06744712Not applicable1 country
- Pilot Study of Management of Facial Paralysis in the Oncologic Patient: Nerve Transfer Techniques to Improve Facial Function and Quality of LifeRecruitingNCT06667427Not applicable1 country
- Clinical Genetics Branch Eligibility Screening SurveyNot yet recruitingNCT070052971 country
- Study of the Use of Venetoclax in Participants With Chronic Lymphocytic Leukemia (CLL) Under Real-Life SettingRecruitingNCT033421443 countries
- Facilitators and Barriers to Cancer Treatment Among Texas ResidentsNot yet recruitingNCT07105046Not applicable1 country
- A Study of JNJ-88549968 for the Treatment of Calreticulin (CALR)-Mutated Myeloproliferative NeoplasmsRecruitingNCT06150157Phase 110 countries
- A Study to Learn About the Study Medicine Called Ponsegromab in Adults With Lung Cancer-Associated Significant Body Weight LossNot yet recruitingNCT07663630Phase 12 countries
- Solid Tumor Analysis for HLA Loss of Heterozygosity (LOH) and Apheresis for CAR T- Cell ManufacturingRecruitingNCT049811191 country
- Multitargeted Recombinant Ad5 PSA/MUC-1/Brachyury-Based Immunotherapy (TriAdeno) Vaccine With IL-15 Superagonist N-803 in Participants With Clinically Localized Prostate Cancer Undergoing Active SurveillanceNot yet recruitingNCT07574541Phase 21 country
- Testing the Addition of Herceptin Hylecta or Phesgo to the Usual Chemotherapy for HER2 Positive Endometrial Serous Carcinoma or CarcinosarcomaRecruitingNCT05256225Phase 33 countries
- Hepatic Artery Infusion of Carfilzomib in Participants With Liver Metastatic Disease Previously Treated With Hepatic Artery Infusion Pump TherapyNot yet recruitingNCT07715903Phase 11 country
- A Study of JNJ-87890387 for Advanced Solid TumorsRecruitingNCT06178614Phase 13 countries
- DEprescribing: Perceptions of PAtients Living With Advanced CancerRecruitingNCT061930831 country
- Liquid Biopsy Evaluation and Repository Development at Princess MargaretRecruitingNCT037023091 country
- Effects of Online Yoga on the Quality of Life of Breast Cancer PatientsRecruitingNCT05327543Not applicable1 country
- A Study of JNJ-87704916, as Monotherapy and in Combination for Advanced Solid TumorsRecruitingNCT06311578Phase 14 countries
- A Study of MK-5684 in People With Certain Solid Tumors (MK-5684-015/OMAHA-015)RecruitingNCT06979596Phase 213 countries
- A Study to Learn About the Medicine Ponsegromab in Adults With Cancer of the Pancreas Which Has Spread and Caused Significant Body Weight Loss and FatigueRecruitingNCT06989437Phase 2/321 countries
- A Study Evaluating Sotorasib Platinum Doublet Combination Versus Pembrolizumab Platinum Doublet Combination as a Front-Line Therapy in Participants With Stage IV or Advanced Stage IIIB/C Nonsquamous Non-Small Cell Lung Cancers (CodeBreaK 202)RecruitingNCT05920356Phase 338 countries
- A Study of GSK5764227 in Combination With Standard of Care (SoC) or Other Agents in Participants With Advanced Solid TumorsRecruitingNCT07277270Phase 16 countries
- Pharmacokinetics, Safety, and Immunogenicity Comparison of Bmab1700 and Opdivo® as Adjuvant Monotherapy in Participants With MelanomaRecruitingNCT07476326Phase 110 countries
- A Study of NEOK001, a B7-H3 and ROR1 Targeting Bispecific ADC in Participants With Select Solid TumorsRecruitingNCT07612176Phase 11 country
- SAFE.AI: Developing and Testing an AI-based Hybrid Chatbot for Financial Empowerment in Rural Cancer CareRecruitingNCT07410689Not applicable1 country
- A Study of JNJ-1761981 in Participants With Solid TumorsRecruitingNCT07525141Phase 11 country
- A Study to Assess Adverse Events and Change in Disease Activity of Intravenous (IV) Telisotuzumab Adizutecan, Monotherapy or in Combination With Osimertinib, Compared to Standard of Care in Adult Participants With Locally Advanced or Metastatic EGFR-Mutated Non-Squamous Non-Small Cell Lung CancerRecruitingNCT07155187Phase 2/320 countries
- Beginning Radiation Immediately With GammaTile at GBM Excision Versus Standard of CareRecruitingNCT07195591Phase 31 country
- First Time in Human (FTIH) Study to Investigate the Safety and Preliminary Activity of GSK5533524 Alone or in Combination in Adult Participants With Advanced Solid TumorsRecruitingNCT07438782Phase 18 countries
- A Study of Ifinatamab Deruxtecan in Pediatric Participants With Relapsed or Refractory Solid Tumors (MK-9999-01D/LIGHTBEAM-U01)RecruitingNCT07630974Phase 1/210 countries
- TheraSphere Japan Pre-Market StudyRecruitingNCT07377487Not applicable1 country
- Clinical Study of MK-4884 in Participants With Advanced or Metastatic Solid Tumors (MK-4884-001)RecruitingNCT07600749Phase 15 countries
- Integration of Palliative Care in Pediatric Onco-hematologyNot yet recruitingNCT07838168
- Early Clonal Dynamics During Venetoclax Treatment for Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL)RecruitingNCT03986034Phase 21 country
- Resistance Training and Creatine Supplementation for Head and Neck CancerNot yet recruitingNCT07838090Not applicable1 country
- Multidisciplinary Intervention for Adults With Chronic Graft-versus-host DiseaseRecruitingNCT06910969Not applicable1 country
- A Study of Zolbetuximab Together With Pembrolizumab and Chemotherapy in Adults With Gastric CancerRecruitingNCT06901531Phase 322 countries
- A Tailored Medication Adherence-Promotion Intervention for Adolescents and Young Adults With CancerRecruitingNCT07223463Not applicable1 country
- Novel Indenoisoquinolone CMYC/TOPOISOMERASE 1 Inhibitor (LMP744) in Recurrent GlioblastomaRecruitingNCT07416188Phase 1/21 country
- Keep Social Randomized Controlled Trial for Young Adults With CancerNot yet recruitingNCT07788339Not applicable1 country
- Pan Tumor Rollover StudyRecruitingNCT03899155Phase 238 countries
- Monitoring Treatment Response With Urine and Serum Metabolome Markers in Patients Treated With Novel Hormone Therapy and Have Either Hormone Sensitive Metastatic Prostate Cancer or Disease Progression on Treatment.Not yet recruitingNCT078370631 country
- Body Mass Index (BMI) and Quality of Life (QoL) in Cancer PatientsRecruitingNCT038730641 country
- Association Between 4D MRI Parameters and the Clinical Characteristics and Prognosis of Major Chronic DiseasesRecruitingNCT076786061 country
- Intratumoral N17350 in Advanced Solid TumorsRecruitingNCT07339176Phase 1/22 countries
- Pivotal Open-label Phase 3 Clinical Study of QTX-2101 in Adult Patients With Acute Promyelocytic LeukemiaRecruitingNCT07504458Phase 35 countries
- Extension Study for Participants in Studies That Include Belzutifan (MK-6482-043/LITESPARK-043)RecruitingNCT07405164Phase 322 countries
- A Study to Evaluate Adverse Events and Change in Disease Activity of Intravenous ABBV-706 Versus Standard of Care in Adult Participants With Relapsed/Refractory Small Cell Lung CancerRecruitingNCT07365241Phase 310 countries
- Data Collection, Clinical Care and Interventions in CCR, NCIEnrolling by invitationNCT009230651 country
- Intervention for Chronic Insufficient Sleep in Young Adult Cancer Patients and SurvivorsNot yet recruitingNCT07318545Not applicable